This page was added on 04 June 2018.
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in people aged ≥12 months.
Monovalent hepatitis A vaccine
Each 1.0 mL monodose vial or pre-filled syringe contains:
- approximately 50 units of hepatitis A virus protein
- 0.45 mg aluminium as aluminium hydroxide
- 70 µg borax
Each 0.5 mL monodose vial or pre-filled syringe contains:
- approximately 25 units of hepatitis A virus protein
- 0.225 mg aluminium as aluminium hydroxide
- 35 µg borax
Both formulations contain traces of:
- bovine serum albumin
For Product Information and Consumer Medicine Information about Vaqta visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.